# Daisy Pharma Opioid Venture, LLC — Form D

Daisy Pharma Opioid Venture, LLC of SCOTTSDALE, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-06. The offering totals $75.0M. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-02-06
- Form: D
- Accession: 0001729659-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $75.0M
- Remaining: $75.0M
- Minimum investment: $1.0M
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-304949

## Issuer

- Name: Daisy Pharma Opioid Venture, LLC
- CIK: 0001729659
- Entity type: Limited Liability Company
- Jurisdiction: ARIZONA
- Incorporated: 2017
- Address: 23623 N. Scottsdale Rd., #D3269, SCOTTSDALE, AZ, 85255
- Phone: 480-355-9000

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Brent Berj Nerguizian | Executive Officer | Scottsdale, AZ |
| Kendric Burton Speagle | Executive Officer | Scottsdale, AZ |

## More

- [CIK 1729659 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1729659&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001729659-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.